Simplex Trading
BBC icon

Simplex Trading’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Simplex Trading’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,661
Closed -$99K – 8544
2025
Q3 		$99K Buy
+3,661
New +$83.5K ﹤0.01% 5755

Other funds holding BBC

Kera Capital Partners
Kera Capital Partners San Jose, California $1.04B AUM 52.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MCP
Militia Capital Partners Las Vegas, Nevada $435M AUM 65.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Simplex Trading's BBC Position: Q4 2025 in Review

Simplex Trading sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2025, closing a stake of 3,661 shares — an estimated $99K sold.

Simplex Trading first reported a position in BBC in Q3 2025 and held it in 1 quarter. The position peaked at $99K in Q3 2025. 19 funds tracked by Wall St. Rank hold BBC as of Q4 2025.

  • Simplex Trading reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 3,661 Virtus Biotech Clinical Trials ETF shares in Q4 2025, an estimated $99K.
  • Simplex Trading first reported a position in Virtus Biotech Clinical Trials ETF in Q3 2025 and held it in 1 quarter.
  • Simplex Trading's Virtus Biotech Clinical Trials ETF position peaked at $99K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.